Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Biphenyl-2,3-diol 1,2-dioxygenase is an iron(II)-dependent enzyme (EC 1.13.11.39) that catalyzes the first aromatic ring cleavage step in the microbial degradation of biphenyl and related compounds, including polychlorinated biphenyls (PCBs). It acts by incorporating two atoms of molecular oxygen into 2,3-dihydroxybiphenyl, producing 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid, and plays a crucial role in environmental biodegradation and pollutant detoxification. It is not relevant as a human therapeutic target but is important in bioremediation processes. The corresponding gene, bphC, encodes this enzyme in bacteria such as Burkholderia xenovorans and Pseudomonas resinovorans.
Ring cleavage of 2,3-dihydroxybiphenyl by incorporation of molecular oxygen, producing 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid and H+
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Biphenyl-2,3-diol 1,2-dioxygenase.